Form 4: Citizens, Inc. Chief Legal Officer Sheryl L. Kinlaw Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Sheryl L. Kinlaw, Chief Legal Officer of Citizens, Inc., reports multiple acquisitions and disposals of Class A Common Stock and Restricted Stock Units (RSUs) through stock investment plans and vesting of previously granted awards.
Summary
- Sheryl L. Kinlaw, the Chief Legal Officer of Citizens, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- The reported transactions include the acquisition of Citizens, Inc. Class A Common Stock through the company's Stock Investment Plan at prices ranging from $2.09 to $2.83 per share.
- Kinlaw also acquired shares through the vesting of Restricted Stock Units (RSUs).
- Disposals of shares occurred to cover tax obligations related to the vesting of RSUs at a price of $2.14 per share.
- New grants of RSUs were awarded on March 28, 2024, under the Citizens, Inc. Omnibus Incentive Plan, vesting in three equal annual installments.
- After these transactions, Kinlaw directly owns 29,846.6526 shares of Citizens, Inc. Class A Common Stock and 106,299 Restricted Stock Units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions reflect standard compensation practices and continued investment by the officer in the company's stock. There are no indications of significant concerns or negative developments.
Positives
- The acquisition of shares through the Stock Investment Plan demonstrates the officer's continued investment in the company.
- The granting of new RSUs aligns the officer's interests with the long-term performance of the company.
Negatives
- The disposal of shares to cover tax obligations, while a normal occurrence, slightly reduces the officer's holdings.
Risks
- Significant fluctuations in the stock price could impact the value of the officer's holdings and potentially influence future decisions regarding stock transactions.
- Changes in company performance or strategic direction could affect the vesting and value of the RSUs.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs extend to 2027, indicating a continued alignment of the officer's interests with the company's long-term performance.
Industry Context
Form 4 filings are a standard part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. This filing is typical for executives receiving stock-based compensation and participating in company stock purchase plans.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies to incentivize executives and align their interests with shareholders.
- The vesting schedules for the RSUs are typical, with annual installments over a three-year period.
- Similar to executives at companies like Prudential Financial or MetLife, Kinlaw's stock transactions reflect a mix of regular stock purchases and equity-based compensation.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding the officer's investment in the company.
- The vesting of RSUs incentivizes the officer to contribute to the company's long-term success, benefiting shareholders.
Next Steps
- Continued monitoring of insider transactions to assess management's confidence in the company's prospects.
- Tracking the vesting of RSUs and any subsequent stock transactions by the officer.
Key Dates
| Date | Description |
|---|---|
| 07/01/2021 | Reporting person was granted an award of RSUs, vesting in three equal annual installments on the first anniversary date of the grant (July 1, 2022) and the second anniversary date of the grant (July 1, 2023) and the third anniversary date of the grant (July 1, 2024) |
| 03/31/2022 | Reporting person was granted an award of restricted stock units (RSUs), vesting in three equal annual installments on the first anniversary of the date of the grant (March 31, 2023) and the second anniversary of the date of the grant (March 31, 2024) and the third anniversary of the date of the grant (March 31, 2025). |
| 03/31/2023 | Reporting person was granted an award of RSUs, vesting in three equal annual installments on the first anniversary of the date of the grant (March 31, 2024) and the second anniversary of the date of the grant (March 31, 2025) and the third anniversary of the date of the grant (March 31, 2026). |
| 01/05/2024 | Transaction date for the acquisition of 173.863 shares of Citizens, Inc. Class A Common Stock at $2.83 per share. |
| 01/19/2024 | Transaction date for the acquisition of 193.0423 shares of Citizens, Inc. Class A Common Stock at $2.55 per share. |
| 02/09/2024 | Transaction date for the acquisition of 177.862 shares of Citizens, Inc. Class A Common Stock at $2.77 per share. |
| 02/23/2024 | Transaction date for the acquisition of 182.6953 shares of Citizens, Inc. Class A Common Stock at $2.7 per share. |
| 03/08/2024 | Transaction date for the acquisition of 200 shares of Citizens, Inc. Class A Common Stock at $2.46 per share. |
| 03/22/2024 | Transaction date for the acquisition of 234.9043 shares of Citizens, Inc. Class A Common Stock at $2.09 per share. |
| 03/28/2024 | Reporting person was granted an award of restricted stock units (RSUs) under the Citizens, Inc. Omnibus Incentive Plan for 2023 pay-for-performance and 2024 long-term incentive. |
| 03/31/2024 | Vesting date for RSUs granted in 2022 and 2023; disposal of shares to cover tax obligations. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.